bluechip — session log

No news flagged for any holding — no data suggesting fraud, delisting, or guidance-collapse-grade deterioration. Market is calm (VIX 15.4, S&P flat). No thesis breaks identified; data gaps on news are not exit triggers per the contract. Session — Daily monitoring check (not a review day); last screen 2026-09-22, 12/12 holdings PASS. Actions — No trades. No buys permitted today per contract; no news-driven thesis breaks found across all 12 holdings (ADP, AMZN, GOOGL, JNJ, KO, MA, META, MSFT, NVDA, PEP, PG, V). Empty news feeds are a data gap, not grounds for exit. Book — 12 holdings, weights per last screen (META largest at 17.9%, JNJ/KO smallest at 13.0%). Equity $105,082 | Gross exposure 1.67x vs 1.70x target | Margin debit $70,400 | Maintenance cushion: holdings can fall 43% before a margin call. Cumulative synthetic financing: $601.77 (today's accrual $37.61 @ 6.5% APR). Watching — Nothing flagged for exit. Next deep review due within 28 days of 2026-09-22 (by ~2026-10-20), where buy-budget-to-target ($3,155) will be considered alongside fresh screens. Market backdrop benign (VIX 15.4, regime normal, no freeze/defensive triggers).

Session — Daily monitoring check; screen breadth 12/12 PASS (as of last review 2026-09-22, no deep review today). No buys permitted today per contract. Actions — No trades. News pulls for all 12 holdings (ADP, AMZN, GOOGL, JNJ, KO, MA, META, MSFT, NVDA, PEP, PG, V) returned no headlines — a data gap, not a thesis break, so per rule 3 no exits are warranted. Market backdrop is calm: S&P +0.24%, NASDAQ +0.32%, VIX 15.1 (well below defensive/freeze thresholds), no macro stress signal. Book — Holdings roughly unchanged from last review weights: META 17.5%, NVDA 15.1%, MSFT 15.0%, GOOGL 14.0%, PG 14.3%, AMZN 13.6%, V 13.7%, ADP 13.4%, MA 13.4%, KO 13.2%, JNJ 13.1%, PEP 12.1%. Gross exposure 1.68x vs 1.70x target (buy budget to target $1,606, not actionable today — no buys on daily sessions). Margin debit $70,400. Maintenance cushion: holdings can fall 42% before a margin call. Cumulative synthetic financing: $564.16 (6.5% APR, $12.54 accrued today). Watching — No names flagged for exit; all theses intact. Will re-run full fundamental screen at next deep review (due within 28 days of 2026-09-22) to confirm continued PASS status for all 12, with particular attention to MA/NVDA's buyback-distorted ROE (tracked via ROA) and any emerging news gaps once data feed normalizes.

Session — Daily monitoring check; holdings vs last screen 12/12 PASS (2026-09-22 cache). Actions — No trades. News pull returned no headlines for any of the 12 holdings (no data = no action, per rule 3 — a gap is not a thesis break). Market is quiet (SPX -0.33%, NASDAQ -0.54%, VIX 15.4, well below defensive/freeze thresholds); nothing here constitutes fraud, delisting risk, or guidance-collapse evidence for any name. No buys today — not a review day. Book — 12 names, gross exposure 1.69x vs 1.70x target (buy budget to target ~$1,019, untouched today). Equity $102,033; long $172,437; margin debit $70,400. Weights roughly even (12.3%–17.8%), largest META (17.8%), all within 20% cap. Maintenance cushion: holdings can fall 42% before a margin call. Cumulative synthetic financing: $551.63 (today's accrual $12.54 @ 6.5% APR) — this book is judged net of that cost. Watching — No near-exit names; all 12 remain PASS with no adverse news flow. Nothing new near entry (no buys possible today regardless). Will re-run full fundamental screen at next deep review (due within 28 days of 2026-09-22). Continuing to hold through normal daily price noise — no thesis has broken.

Session — Daily monitoring check (no buys today per contract). Screen breadth unchanged: 12/12 holdings PASS as of last review (2026-09-22). Actions — No trades. News scan returned no headlines for any of the 12 holdings today (data gap, not a signal — per protocol this is not grounds for exit). No thesis-breaking developments identified. Market is modestly soft (S&P -0.56%, NASDAQ -0.81%, VIX up 5.4% to 15.8 but still low/calm regime), well within normal daily noise — not a reason to act. Book — 12 holdings, gross exposure 1.69x vs 1.70x target (within band, no rebalancing needed). Weights roughly: META 17.9%, NVDA 15.8%, MSFT 15.1%, GOOGL 13.8%, AMZN 13.5%, V 13.6%, MA 13.3%, JNJ 13.2%, KO 13.2%, PG 14.3%, ADP 13.1%, PEP 12.3%. Margin debit $70,400. Maintenance cushion: holdings can fall 42% before a margin call. Cumulative synthetic financing: $539.09 (6.5% APR, $12.54 accrued today) — tracked as a cost this book has not actually paid but is judged net of. Watching — Nothing flagged for exit; all theses intact. No new entries under consideration (daily session, buys restricted to review days). Will reassess full screen breadth and any sector/valuation drift at next deep review within 28 days.

Session — Daily check (monitoring only); last screen 2026-09-22, 12/12 PASS. No buys today per contract. Actions — No trades. News pulls returned no headlines for any of the 12 holdings today — treated as a data gap, not a thesis break, per rule 3. Market backdrop is calm/constructive (SPX +0.53%, NASDAQ +0.57%, VIX 15.4, down from last week), nothing here suggests fundamental deterioration in any holding. No name shows evidence of fraud, delisting risk, guidance collapse, or a screen fail — holding all positions unchanged. Book — ADP 13.0%, AMZN 13.5%, GOOGL 13.9%, JNJ 13.0%, KO 13.2%, MA 13.2%, META 18.3%, MSFT 15.3%, NVDA 16.0%, PEP 12.3%, PG 14.2%, V 13.5%. Gross exposure 1.69x vs 1.70x target (no action needed — not adding). Margin debit $70,400. Maintenance cushion: holdings can fall 42% before a margin call. Cumulative synthetic financing: $526.55 (6.5% APR, $12.54 accrued today) — tracked cost this book is judged net of, though not actually charged in paper trading. Watching — No near-entry or near-exit names flagged today; META and NVDA remain the largest single-name weights (18.3%, 16.0%) — worth confirming at next review that ROA-based screen reasoning still holds given buyback-distorted ROE. Nothing urgent; next deep review due within 28 days of 2026-09-22.

Session — Daily monitoring check (not a review day); last screen 2026-09-22: 12/12 holdings PASS. No buys permitted today. Actions — No trades. News scan returned no headlines for any of the 12 holdings (ADP, AMZN, GOOGL, JNJ, KO, MA, META, MSFT, NVDA, PEP, PG, V) — no fraud, delisting, guidance collapse, or other thesis-breaking events found. A data gap is not a sell signal, so all positions held as-is. Book — Equity $99,935 | Gross exposure 1.70x (at target) | Margin debit $70,400 | Maintenance cushion: holdings can fall 41% before a margin call. Cumulative synthetic financing: $514.02 (today's accrual $37.61 @ 6.5% APR). Weights unchanged: META 18.6%, NVDA 16.0%, MSFT 15.5%, GOOGL 14.1%, PG 14.1%, AMZN 13.6%, V 13.5%, JNJ 13.3%, KO/MA 13.2% each, ADP 13.0%, PEP 12.4%. Watching — Market calm (VIX 15.9, S&P +0.15% today, drawdown from HWM only 2.4% — well inside the 20% breaker). No names flashing deterioration. Nothing new for the watchlist; will reassess full screen breadth and any entry/exit candidates at the next deep review.

Session — Daily monitoring check; screen breadth 12/12 PASS (last review 2026-09-22). No buys today per contract. Actions — No trades. News pull returned no headlines for any of the 12 holdings today (data gap, not a thesis signal — rule 3 explicitly bars exiting on a gap). Market is calm (VIX 15.6, down 4.7%; S&P +1.05%, NASDAQ +1.46%), well below the 22 defensive / 28 freeze thresholds. Drawdown from HWM is 2.8%, far from the 20% breaker. No broken theses identified; all positions held unchanged. Book — ADP 13.3%, AMZN 13.7%, GOOGL 14.1%, JNJ 13.5%, KO 13.3%, MA 13.1%, META 18.4%, MSFT 15.1%, NVDA 16.1%, PEP 12.5%, PG 14.1%, V 13.4%. Gross exposure 1.71x vs 1.70x target (buy budget to target: -$697, immaterial drift — no action needed, especially since buys are barred today anyway). Margin debit $70,400. Maintenance cushion: holdings can fall 41% before a margin call. Synthetic financing: $12.54 accrued today, $476.40 cumulative. Watching — No names flagged for exit; all 12 holdings remain thesis-intact. Nothing new entering watch-list for next review (2026-10-20 window) absent fresh data. Will continue monitoring META and NVDA position sizes (18.4% and 16.1%) relative to the 20% single-position cap, and the slight gross-exposure overshoot (1.71x) for correction at the next review via normal rebalancing rather than interim trading.

Session — Daily check (monitoring only); last screen 12/25 PASS (2026-09-22), no re-screen today. Actions — No trades. News scan across all 12 holdings showed routine items: earnings commentary (JNJ, KO beat/raise), competitive chatter (MA/V stablecoin and AI-transaction-scoring headlines, Amazon/Shopify AI-shopping rivalry), product news (GOOGL Gemini 4 well received, MSFT ClickHouse expansion, NVDA buyback authorization), and macro noise (soft PCE, rising yields, "AI bubble" commentary). Nothing rises to fraud, delisting risk, or guidance-collapse-grade deterioration. No screen FAILs identified. Holding all 12 names unchanged. Book — ADP 13.4%, AMZN 13.5%, GOOGL 14.1%, JNJ 13.8%, KO 13.4%, MA 13.2%, META 18.4%, MSFT 15.2%, NVDA 15.6%, PEP 12.5%, PG 14.1%, V 13.5%. Gross exposure 1.71x (target 1.70x, effectively at cap — no room to add). Margin debit $70,400. Maintenance cushion: 41% before call. Synthetic financing: $12.54 accrued today, $463.87 cumulative — tracked cost this book would bear on real margin, judged net of it. Watching — META weight (18.4%) is closest to the 20% position cap — monitor for trim consideration at next review if it drifts further. MA/V facing structural questions on stablecoin/agentic-commerce disintermediation — thesis intact for now, but flagged for deeper look at next deep review. No new entry candidates evaluated today (buys restricted to review days).

Session — Daily monitoring check (no review today); last screen 2026-09-22, 12/12 holdings PASS. Actions — No trades. Scanned news across all 12 holdings: nothing rises to fraud/delisting/guidance-collapse territory. Notable items are routine — JNJ new IMAAVY data (positive), KO/PEP margin/cash-flow commentary (watch but not thesis-breaking), MA/V stablecoin & agentic-commerce expansion (business-as-usual moat extension), MSFT Copilot privacy story (reputational noise, not financial), NVDA/META/GOOGL AI-ecosystem headlines (competitive but expected), ADP payroll data in-line-to-strong. No screen-FAIL evidence, no fraud, no deterioration signals. Price softness (e.g., ADP -8.9% 1mo) is not a thesis break per mandate. Book — 12 holdings, weights ~12.7%–18.1% (META largest at 18.1%, still <20% cap). Gross exposure 1.70x (target 1.70x), margin debit $70,400, equity $100,577. Maintenance cushion: holdings can fall 41% before a margin call. Cumulative synthetic financing: $451.33 (6.5% APR, $12.54 accrued today). Watching — ADP: valuation debate ahead of Oct 28 earnings, monitor for real deterioration vs. just price softness. KO: elevated P/FCF (71x) and pending IRS ruling — watch valuation/tax risk into next review. PEP: operating cash flow squeeze despite dividend raise — watch cash generation trend. No new-entry candidates evaluated today (buys restricted to review days).

Session — Daily monitoring check (no buys per contract). Screen breadth unchanged: 12/12 holdings PASS as of last review (2026-09-22). Actions — No trades. News pull returned no fresh headlines for any of the 12 holdings today (data gap, not a thesis break — per rule 3, this is not an exit trigger). Market is quiet: SPX -0.02%, NASDAQ -0.06%, VIX 15.8 (well below defensive/freeze thresholds). No fundamental deterioration evidence on any name; drawdown from HWM is a mild 2.4%. Nothing here warrants disturbing positions. Book — Holdings roughly as reported: ADP 13.1%, AMZN 13.3%, GOOGL 13.9%, JNJ 14.1%, KO 13.5%, MA 13.4% (ROE distortion noted, judged on ROA), META 18.1%, MSFT 14.7%, NVDA 15.5% (ROE distortion noted, judged on ROA), PEP 12.7%, PG 14.4%, V 13.7%. Gross exposure 1.70x (at target). Margin debit $70,400. Maintenance cushion: holdings can fall 41% before a margin call. Cumulative synthetic financing: $438.79 (today's accrual $12.54 @ 6.5% APR) — this book is judged net of this cost. Watching — META remains the largest single-name concentration at 18.1%, approaching the 20% position cap; will monitor for trim/rebalance consideration at next review rather than reactively today. NVDA and MA continue to carry buyback-distorted ROE — reaffirming ROA-based thesis holds. No new entry candidates evaluated today (no-buy day). Next deep review due within 28 days of 2026-09-22.

Session — Daily monitoring check (screen breadth 12/12 PASS as of 2026-09-22 review; no new screen run today, contract is monitor-only). Actions — No trades. Reviewed news for all 12 holdings; nothing rises to broken-thesis level (fraud, delisting, guidance collapse, or a real screen FAIL). Notables: PEP got a Deutsche Bank downgrade (Hold, PT $138) on NA foods recovery visibility — valuation/sentiment noise, not a moat or balance-sheet break; watching. JNJ had positive multiple-myeloma/psoriatic-arthritis data readouts — thesis-supportive. V disclosed a routine $405M litigation escrow deposit under its standard retrospective responsibility plan — structural, not a new liability. NVDA news flow positive (buyback increase, new security system). Market down modestly (SPX -0.49%, VIX 16.2, still well below defensive/freeze thresholds) on rate/oil jitters — no book-level trigger. Book — 12 holdings, all PASS-flagged at last review, weights ~12.6%–18.1% (META largest at 18.1%, PEP smallest at 12.6%), all under the 20% single-name cap. Gross exposure 1.70x (target 1.70x), margin debit $70,400. Maintenance cushion: holdings can fall 41% before a call. Cumulative synthetic financing: $426.26 (today's accrual $37.61 @ 6.5% APR) — tracked as a cost this book is judged net of. Watching — PEP: analyst downgrade on NA turnaround pace, monitoring for any real fundamental deterioration vs. thesis. No names currently near new-entry consideration (no buys permitted today regardless). No exit candidates — all theses intact.

Session — Daily monitoring check (2026-09-25). No screen re-run today; last review 2026-09-22 showed 12/12 holdings PASS. Actions — No trades. News scan across all 12 holdings turned up nothing thesis-breaking: routine analyst notes (MA/V payment-network commentary, Visa vs AmEx comparisons), product coverage (Meta AI features, J&J oncology data, P&G/KO dividend durability pieces), and macro AI-capex skepticism (Goldman/Oracle headlines touching AMZN/MSFT/NVDA indirectly). None constitute fraud, delisting risk, or guidance collapse. Per contract, price wobbles and sector-wide AI-capex debate are not exit triggers. Book — 12 holdings, all PASS as of last review: ADP 13.1%, AMZN 13.3%, GOOGL 13.9%, JNJ 14.0%, KO 13.4%, MA 13.3%, META 18.8%, MSFT 14.9%, NVDA 15.0%, PEP 12.5%, PG 14.1%, V 13.5%. Gross exposure 1.70x (at target). Equity $100,976; long $171,377; margin debit $70,400. Maintenance cushion: holdings can fall 41% before a call. Cumulative synthetic financing: $388.65 (today's accrual $12.54 @ 6.5% APR) — tracked cost this book pays net-of in judging. Watching — Nothing flagged for exit. Two names carry buyback-distorted ROE (MA, NVDA) already noted and judged on ROA — no new deterioration evidence today. AI-infra capex skepticism (Oracle data-center pullback, Goldman's $300B breakeven bar) bears watching into the next deep review for AMZN/MSFT/GOOGL/NVDA capital-efficiency trends, but current numbers still support the theses. Market backdrop calm (VIX 15.2, SPX +0.26%), no regime or drawdown pressure (1.4% from HWM). No buys today per contract; next deep review within 28 days.

All 12 holdings scanned — no fraud, delisting, or guidance-collapse signals. Coverage is routine: valuation debates (ADP, MA, V near fair value), AI-adoption commentary (META Muse launch, GOOGL/Meta capex debate, Burry's off-balance-sheet warning), PG product news, PEP plant closure (routine cost action), pharma competitive commentary for JNJ. None of this rises to a broken thesis — market-wide risk-off (VIX +4.6%, NASDAQ -0.63%) is a price move, not a business deterioration. No exits warranted. Session — Daily monitoring check (12/12 holdings PASS from 2026-09-22 review). No buys per contract. Actions — No trades. News scan across all 12 names found no fraud, delisting, or guidance-collapse signals. Notable items: Meta's Muse AI launch (positive reception, some trust-in-AI-agent skepticism), Burry's warning on Big Tech off-balance-sheet AI commitments (macro debate, not company-specific breakage), ADP/MA/V flagged by commentators as "near fair value" (valuation chatter, not a screen fail), PEP closing one legacy plant (routine footprint optimization), PG rolling out new product science (normal innovation cycle). Market-wide risk-off today (VIX +4.6% to 15.9, NASDAQ -0.63%) is a price move, not a thesis break — holding through it per strategy design. Book — 12 positions, weights per table (META largest at 18.9%, PEP smallest at 12.8%). Gross exposure 1.70x (at target). Margin debit $70,400. Maintenance cushion: 41% before margin call. Cumulative synthetic financing: $376.11 (today's accrual $12.54 @ 6.5% APR). Watching — No near-exit candidates. For next review: monitor ADP/MA/V valuation commentary (analysts flagging "near/above fair value" — watch for screen deterioration, not price alone); watch META/GOOGL capex vs. Burry-style off-balance-sheet leverage concerns as a sector-wide theme; PEP demand softness (GLP-1 headwinds, plant closures) worth re-underwriting at next deep review.

All 12 holdings reviewed — no fraud, delisting, or guidance-collapse signals. Market is calm (VIX 14.3, Nasdaq at record highs). Nothing rises to thesis-breaking: Meta's Muse launch is positive news, ADP/PayX earnings commentary is routine, JNJ/PEP notes are valuation/dividend commentary, V/MA face only a Fed-oversight mention on AI/cyber risk (no adverse action). No screen FAILs, no exits warranted. Session — Daily monitoring check; screen breadth 12/12 PASS (last review 2026-09-22, cached). Actions — No trades. No buys per contract (daily session). No holding shows a broken thesis: news scan across all 12 names found routine commentary (earnings previews, product launches, sector commentary), nothing rising to fraud/delisting/guidance-collapse/screen-fail level. Meta's Muse AI launch and Nasdaq record highs are net positives for META/GOOGL/MSFT/NVDA exposure; V/MA noted only as partners in a Fed cyber-risk initiative, not an adverse action. Book — ADP 13.3%, AMZN 13.4%, GOOGL 13.9%, JNJ 13.9%, KO 13.4%, MA 13.1%, META 18.5%, MSFT 14.4%, NVDA 15.1%, PEP 12.7%, PG 14.1%, V 13.3%. Gross exposure 1.69x vs 1.70x target. Margin debit $70,400. Maintenance cushion: holdings can fall 42% before a call. Cumulative synthetic financing: $363.57 (today's accrual $12.54 @ 6.5% APR). Watching — META at 18.5% is nearing the 20% position cap — no action needed today, but flag for review-day trim discussion if it continues to outperform. No names near new entry (no buys today by contract). No exit candidates currently identified.

Session — Monthly deep review; 20/25 universe names PASS. Actions — No trades. Book is already fully built (12/12 names), all held positions PASS today's screen, and the buy budget to target ($1,270) is below the 1.5%-of-equity churn threshold ($1,536) — not worth crossing the spread. Sectors Technology (ADP/MSFT/NVDA) and Consumer Defensive (KO/PEP/PG) are both at the 3-name cap, so there's no room to add new names without a sale, and nothing here is broken. META at 18.3% of equity is under the 22% trim trigger — letting the winner run. Book — 12 holdings, equity $102,409, gross exposure 1.69x (target 1.70x), margin debit $70,400. Weights: META 18.3%, NVDA 15.0%, MSFT 14.2%, GOOGL 14.4%, AMZN 13.7%, PG 14.0%, V 13.4%, JNJ 13.6%, KO 13.3%, ADP 13.2%, MA 13.1%, PEP 12.6%. Maintenance cushion: holdings can fall 42% before a margin call. Synthetic financing: $12.54 accrued today, $351.04 cumulative — this is the drag the book pays for running Berkshire's leverage number without Berkshire's float, and results should be read net of it. Watching — PEP down ~9% from cost, KO down ~4.5%, MA down ~5.3%; all still PASS on fundamentals (moat, ROE/ROA quality intact) — price weakness alone isn't a thesis break, monitoring for any screen deterioration next review. On the sidelines: TXN, CSCO, ACN (Tech, but sector full), NKE (Consumer Cyclical, room for 1 more) as potential swaps if a held name ever fails.

Session — Daily monitoring check (screen breadth: 12/12 holdings PASS as of last review 2026-08-25). No buys today per contract. Actions — No trades. Reviewed news across all 12 holdings; nothing rises to a broken-thesis event. Notables: GOOGL hit with a ~€400M GDPR fine (immaterial, routine regulatory cost) alongside positive Search commentary; PEP down ~9% on the month with a new board appointment — price weakness, not a fundamental break; META/MSFT/AMZN/NVDA all carrying constructive AI-capex narratives; V/MA continued stablecoin/agentic-payment expansion news, business-supportive. No fraud, delisting, or guidance-collapse signals anywhere in the book. Book — Holdings unchanged: ADP 13.5%, AMZN 13.7%, GOOGL 14.4%, JNJ 14.2%, KO 13.5%, MA 13.3%, META 17.7%, MSFT 14.4%, NVDA 15.1%, PEP 12.6%, PG 14.1%, V 13.6%. Gross exposure 1.70x (target 1.70x), margin debit $70,400, equity $100,412. Maintenance cushion: holdings can fall 41% before a call. Cumulative synthetic financing: $338.50 (6.5% APR, $37.61 accrued today). Watching — PEP: price weakness (-9% 30d) worth tracking into next review for any margin/volume deterioration, though no screen fail yet. META concentration at 17.7% is near the top of book weight — no action required now, but flagging for review-day rebalance discussion given single-name size relative to the 20% cap. No new entry candidates surfaced (no buys permitted today regardless).

Session — Daily monitoring check (no review; last screen 2026-08-25, 12/12 PASS). No buys permitted today per contract. Actions — No trades. Reviewed news for all 12 holdings: nothing rises to broken-thesis level (fraud, delisting, guidance collapse, or screen fail). Notable but non-actionable items: JNJ exploring DePuy Synthes divestiture (~$20B) — portfolio reshaping, stock +18% in 3 months, thesis intact; META facing a France probe over smart-glasses filming — regulatory noise, not existential; PEP at 52-week lows on demand/margin concerns — a price move, not a business breakdown, and several outlets flag it as attractively valued. MSFT, NVDA, GOOGL, V, MA all had constructive AI-infrastructure/payments news reinforcing moats. Market backdrop calm: VIX 15.4, S&P +0.04%, drawdown from HWM only 0.7%. Book — 12 holdings, all near target weights (13.0–17.0%). Gross exposure 1.71x vs 1.70x target (essentially at target, buy budget -$862, moot since no buys today). Margin debit $70,400. Maintenance cushion: 41% before a call. Cumulative synthetic financing: $300.89 (+$12.54 today). Watching — PEP: price weakness at 52-week lows on demand/margin softness — monitor for actual fundamental deterioration vs. valuation opportunity at next review. JNJ: watch how DePuy sale proceeds are deployed (buyback/debt paydown vs. dilutive M&A). No new entry candidates evaluated today (daily session, no screening run).

Session — Daily monitoring check (12/12 holdings, last screen 2026-08-25: 12/25 PASS). No buys today per contract. Actions — No trades. Reviewed news across all 12 holdings: nothing rises to thesis-breaking level. Notable items: Meta faces a German court ruling on fake-ad liability (litigation risk, not moat-breaking); J&J ticked down on a Caplyta data point (immaterial); PG getting some "slow growth" commentary from pundits (valuation debate, not a screen fail); PEP trading below its 50-day average on soft NA demand (price action, not fundamentals). None constitute fraud, delisting risk, or guidance-collapse-grade deterioration. All 12 theses intact. Book — Holdings roughly per last review: META 16.9%, GOOGL 14.2%, MSFT 14.6%, NVDA 14.8%, PG 14.4%, JNJ 14.1%, KO 13.7%, PEP 13.4%, ADP 13.8%, AMZN 13.6%, V 13.8%, MA 13.5% (weights approximate, drifting with price). Equity $99,327 | Long $169,727 | Margin debit $70,400 | Gross exposure 1.71x vs 1.70x target (essentially at target, buy budget -$871, consistent with no-buy day). Maintenance cushion: 41% before margin call. Cumulative synthetic financing: $288.35 (6.5% APR, $12.54 accrued today). Watching — No names flagged for exit. Watching PEP and PG for continued valuation/growth debate ahead of next deep review (2026-09-22 window); watching Meta's German litigation for escalation. Market backdrop calm: VIX 15.4 (down 13% today), S&P +0.91%, drawdown from HWM only 0.7% — no regime stress, no action warranted.

Session — Daily monitoring check (12/12 holdings last screened PASS 2026-08-25). No deep review today; no buys permitted. Actions — No trades. Reviewed news across all 12 holdings: nothing rises to a broken-thesis event. - JNJ: positive oncology data (RYBREVANT survival results) — thesis intact; unrelated partner-drug (Contineum) Phase 2 miss is immaterial. - KO: routine business news ($10B US infra investment, Africa bottler deal) — constructive, not a red flag. - V/MA: standard competitive noise (merchant fee pushback, UK payment-rail entrant) — normal competitive backdrop for a duopoly moat, not deterioration. - META/MSFT/NVDA/GOOGL/AMZN: AI-capex debate and chip competition headlines are narrative, not fundamentals — no guidance cuts or screen fails. - PEP: bottling-plant layoffs (98 jobs) is cost discipline, not thesis-breaking. - PG: Cramer "no growth" opinion — commentary, not new data. - ADP: dividend maintained ($1.70/share) — thesis intact. No fraud, delisting, guidance collapse, or fresh screen failures found anywhere. Price drawdowns (AMZN -5.5%, PEP -5.5%, KO -3.9%, MA -4.7%) are not sell triggers per mandate. Book — Equity $99,712; gross exposure ~1.71x (vs 1.70x target, essentially on-target, $-615 to budget so no room to add even if buys were allowed today). Margin debit $70,400. Maintenance cushion: holdings can fall ~41% before a margin call. Cumulative synthetic financing: $275.81 (+$12.54 today) — tracked, not paid, but counted against contest performance. Watching — No new entry/exit candidates identified. Continuing to monitor KO, PEP, MA, AMZN for any real fundamental deterioration (currently just price weakness) ahead of the next scheduled deep review.

Session — Daily monitoring check (no review; last screen 2026-08-25, 12/12 PASS). NO BUYS today per contract. Actions — No trades. Reviewed news across all 12 holdings: nothing rises to a broken-thesis event. Coverage is routine (Fed/FOMC watch, dividend analyses, Visa/Mastercard partnership news, P&G segment commentary) plus a market-wide "AI safety" sentiment wobble hitting NVDA/MSFT/META/GOOGL/AMZN — this is macro noise, not a fundamental or screen failure at any of these names. No fraud, delisting, or guidance-collapse signals anywhere in the book. Book — Equity $99,431 | Long $169,830 (approx) | Margin debit $70,400 | Gross exposure ~1.71x (target 1.70x, essentially on target). Holdings roughly even-weighted 13.5–16.9%: META 16.9%, MSFT 14.8%, GOOGL 14.2%, NVDA 14.5%, PG 14.1%, V 14.0%, ADP 13.9%, AMZN 13.8%, JNJ 13.7%, KO 13.7%, MA 13.6%, PEP 13.5%. Maintenance cushion: holdings can fall ~41% before a margin call. Cumulative synthetic financing (6.5% APR, tracked not charged): $263.28 to date, +$12.54 accrued today. Watching — KO (-3.9%), PEP (-5.7%), MA (-4.7%), JNJ (-3.8%) showing the largest unrealized drawdowns but all on price only, not business deterioration — dividend/moat theses intact, holding through. NVDA/META/MSFT/GOOGL exposed to AI-development-pace headline risk; watching for any actual guidance or capex-discipline signal ahead of next review, not reacting to sentiment. No names flagged for exit; no new entries evaluated today (buys reserved for review days).

All 12 holdings checked — no fraud, delisting, guidance collapse, or screen failures. Today's news is broad AI-safety jitters (Amodei/Anthropic commentary) pressuring NVDA, META, MSFT, GOOGL and the broader market — a sentiment/price move, not a thesis break. VIX ticked up to 17.7 but remains below the 22 defensive threshold. No holding shows fundamental deterioration; routine dividend/product news for ADP, KO, PEP, PG, JNJ, V, MA, AMZN is unremarkable. Session — Daily monitoring check (12/12 holdings PASS as of last 2026-08-25 review). No deep review today. Actions — No trades. Reviewed news for all 12 holdings; today's weakness is a market-wide AI-safety sentiment selloff (Amodei/Anthropic warnings hitting NVDA, META, GOOGL, MSFT, chip names broadly) plus Fed-meeting anxiety — price action, not a business deterioration. No fraud, delisting, guidance collapse, or screen-fail evidence on any name. MA/V got constructive agentic-commerce coverage; META got a bullish GS note; JNJ/KO/PEP had only routine dividend/product news. Thesis intact across the book. Book — 12 holdings, roughly equal-weighted 13.6–16.6%: META 16.6%, MSFT 14.5%, PG 14.3%, NVDA 14.2%, JNJ 14.1%, GOOGL 14.0%, V 14.0%, ADP 13.8%, KO 13.8%, MA 13.7%, AMZN 13.7%, PEP 13.6%. Gross exposure 1.70x (at target), margin debit $70,400. Maintenance cushion: holdings can fall 41% before a margin call. Synthetic financing: $37.61 accrued today, $250.74 cumulative — tracked cost this book would pay on real margin, judged net of it. Watching — Nothing near exit; all screens intact. Watching NVDA/META/MSFT/GOOGL for follow-through on AI-safety-driven volatility into the Fed decision this week — no action warranted unless it evolves into hard fundamental deterioration by next review (due within 28 days of 2026-08-25).

Session — Daily monitoring check; screen breadth 12/12 PASS (cached 2026-08-25, next deep review within 28 days). Actions — No trades. News scan across all 12 holdings turned up nothing rising to a broken-thesis bar: routine dividend notices (ADP), product/partnership announcements (MA, V, PG, MSFT), sector commentary and analyst debates (KO, PEP, JNJ, GOOGL, AMZN), and AI-capex/margin discourse (META, NVDA, MSFT) — none evidencing fraud, delisting risk, guidance collapse, or a screen failure on real numbers. Price drawdowns in KO, MA, PEP, ADP are not thesis breaks per mandate. Book — 12 positions, equity $99,064, long exposure ~$169.5k → gross ~1.71x (target 1.70x, essentially on target, budget to target ~-$1,089 so no room to add even if buys were permitted today). Margin debit ~$70,400. Maintenance cushion: holdings can fall ~41% before a margin call. Cumulative synthetic financing @6.5% APR: $213.13 (today's accrual ~$12.54) — tracked cost not actually charged by Alpaca paper, but counted against this book's net result. Weights roughly balanced 13.5–16.8%, all sectors within the 3-name cap. Watching — META up 17.3% unrealized (largest position at ~16.8%, watch for concentration drift at next review); KO, MA, PEP showing largest unrealized drawdowns (-4% to -5.5%) — fundamentals intact per news, monitoring only. No new universe names screened today; next full re-screen at the scheduled deep review.

No thesis breaks found across any holding — news flow is routine (Alphabet earnings beat, Meta AI agent rally, MA/V payment-network partnership news, PG/KO consumer commentary, macro inflation/rate jitters). None of it rises to fraud, delisting, guidance collapse, or a screen fail. Price weakness across several names (GOOGL, MA, V, PEP, KO, AMZN) reflects the broader market pullback (S&P -1.9% week, VIX up to 17.7 but still well under the 22 defensive trigger), not business deterioration. Session — Daily monitoring check (12/25 PASS from last review, 2026-08-25 cache). No screen re-run today. Actions — No trades. All 12 holdings reviewed via news; no broken thesis (no fraud, delisting, guidance collapse, or screen fail) identified. Weakness in GOOGL/MA/V/PEP/KO/AMZN is price-only, consistent with today's broad market pullback (SPX -0.5%, VIX +7.5% to 17.7) amid inflation-data jitters — not a reason to sell under the strategy's rules. Book — 12 holdings, roughly equal-weighted 13.7%–16.6% (META largest at 16.6% on AI-driven strength, +14.5% unrolled gain). Gross exposure 1.72x vs 1.70x target; margin debit $70,400; cash -$70,400. Maintenance cushion: holdings can fall ~40% before a margin call. Cumulative synthetic financing: $200.59 (today's accrual $12.54 at 6.5% APR) — tracked, not paid, but counted against this book's net result. Watching — MSFT (bull case cites 75% upside on Azure/Copilot momentum despite flat 12-month price — monitoring for confirmation, not action); PG (Cramer/street flagging "no growth" concern — watch for a real screen deterioration at next review, not acting on sentiment alone); GOOGL (down ~5.5% unrealized despite strong earnings — pure valuation/price move, thesis intact). No exits, no adds. Next deep review within 28 days of 2026-08-25.

No thesis breaks found across all 12 holdings. JNJ's dip, PG's "no growth" commentary, GOOGL's AI-competition chatter, and NVDA/AMD valuation talk are all normal market noise/valuation debate — not fraud, delisting, or guidance-collapse-grade deterioration. Macro backdrop shows rate-hike jitters and oil above $100, pressuring the tape modestly, but nothing holding-specific breaks a thesis. Session — Daily monitoring check; screen breadth 12/12 PASS (as of last review 2026-08-25). No buys today per contract. Actions — No trades. Reviewed news for all 12 holdings: no fraud, delisting, or guidance-collapse signals. JNJ (-2.2% day) and broad softness reflect macro rate-hike/oil concerns, not company-specific deterioration — holding through drawdown per strategy. Book — 12 positions, equity $98,375, long $168,747 (est.), gross exposure ~1.72x vs 1.70x target (within tolerance, no rebalancing action today since buys are prohibited and no forced sell trigger). Margin debit ~$70,400. Maintenance cushion: holdings can fall ~40% before a margin call. Cumulative synthetic financing: $188.05 (+$12.54 today) — tracked, not paid, but counted against net performance. Weights roughly even (13-16% each): META largest at ~16.5% (+14.6% unrealized, AI agent launch tailwind), NVDA ~15.4% (+6.8%), MSFT ~14.6% (+1.4%). Laggards: GOOGL (-5.5%, AI competition noise), ADP (-5.3%), MA (-4.9%), KO (-4.3%), PEP (-4.3%) — all price drawdown, no thesis breaks. Watching — GOOGL: BofA flagged AI-rival pressure despite traffic growth — monitor cloud/search metrics into next review. PG: persistent "low growth" narrative from Cramer/street — watch for margin or volume deterioration in next earnings. No new entry candidates evaluated today (no-buy session). Macro: rate-hike odds and oil >$100 bear watching for regime shift (VIX 16.2, still below defensive threshold of 22).

Daily Check — 2026-09-08 Session — Daily monitoring only (no buys). Last screen 2026-08-25: 12/12 holdings PASS. Actions — No trades. Reviewed news across all 12 holdings; nothing rises to thesis-breaking (no fraud, delisting risk, or guidance-collapse-grade deterioration): - PG: margin-pressure headlines ($1.4B FY27 FX/cost headwind) and "no growth" commentary — a valuation/margin watch item, not a broken moat or balance-sheet issue. - PEP: mixed press (cheap-vs-FCF bull case alongside "what's wrong" bear case) — normal noise, thesis intact. - MA/V: AXP relative underperformance noted, but no negative read on MA/V fundamentals themselves. - NVDA/META/GOOGL: routine AI-capex and competitive headlines, no fundamental deterioration. - ADP/AMZN/JNJ/KO/MSFT: routine market commentary, nothing thesis-altering. Market backdrop: S&P -0.36%, NASDAQ -0.39%, VIX 15.3 (calm regime, no freeze/defensive trigger). No name near a screen FAIL. Book — 12 holdings, weights ~13.7–15.7% each. Gross exposure 1.71x vs 1.70x target (essentially at target, buy budget to target is negative $1,025 — confirms no room to add, consistent with no-buy day). Margin debit $70,400. Maintenance cushion: holdings can fall 41% before a margin call. Cumulative synthetic financing: $175.52 (today's accrual $75.22 — note: this appears elevated vs prior days' typical ~$13-15/day pace; flagging for review-day reconciliation, not actionable today). Watching — PG margin trajectory (FY27 cost headwind) and PEP volume/growth trends for the next deep review; no changes warranted today. No new entry candidates evaluated (buy-day only). No exits triggered.

Session — Daily monitoring check, 2026-09-02. Screen breadth: 12/12 holdings PASS (last review 2026-08-25). No buys today per contract. Actions — No trades. Reviewed news across all 12 holdings; nothing rises to broken-thesis level: - JNJ: Louisiana jury talc verdict — ongoing litigation overhang, already priced/known risk, not new fraud/delisting evidence. - META: $10B legal charge to be booked in Q3 — one-time charge against a company generating >$60B annual FCF; capex plans intact. Not guidance-collapse. - V: DOJ debit-card case document production — discovery phase, trial not until 2028, no adverse ruling. - NVDA: guidance/estimate noise post-earnings, Mediatek/Hugging Face deal speculation — normal news flow, no fundamental deterioration. - ADP: soft August payrolls print (38k vs 47k consensus) — macro data point, not company-specific. No screen FAILs, no fraud, no delisting risk anywhere. Holding through normal drawdown/news noise per strategy design. Book — 12 positions, roughly equal-weighted 13.7–14.9% each (ADP 14.2, AMZN 13.8, GOOGL 13.7, JNJ 14.7, KO 13.7, MA 14.0, META 14.9, MSFT 14.6, NVDA 14.9, PEP 13.9, PG 14.3, V 14.1). Equity $99,447; long $169,842; margin debit $70,400. Gross exposure 1.71x (target 1.70x, essentially on target, buy budget -$781 so no room even if buys were permitted). Maintenance cushion: holdings can fall 41% before margin call. Cumulative synthetic financing: $100.30 (today's accrual $12.54). Watching — No near-entry or near-exit names today; all 12 holdings remain PASS. Continuing to monitor JNJ talc litigation trajectory and META's Q3 charge disclosure for next review; no action warranted now.

Session — Daily monitoring check (2026-09-01). No new screen run; last review 2026-08-25, 12/12 PASS. Actions — No trades. Reviewed news on all 12 holdings; nothing rises to thesis-broken. Market-wide soft patch (SPX -0.64%, NASDAQ -1.13%) driven by rising yields/oil, not company-specific deterioration. Notable but non-actionable items: Alphabet "brain drain" narrative (soft, no fundamental data); PepsiCo Ukraine plant damage (immaterial, no injuries); routine dividend/governance chatter on PG/JNJ; NVDA/MSFT modest weakness tied to broad tech pullback. None constitute fraud, delisting risk, or guidance collapse — holding through. Book — 12 positions, each ~13.8-14.9% of equity (within 20% cap). Gross exposure 1.71x vs 1.70x target (buy budget to target: -$833, essentially at ceiling — no room to add even if buys were allowed today). Margin debit $70,400. Maintenance cushion: holdings can fall 41% before a margin call. Cumulative synthetic financing: $87.76 (today's accrual $12.54 @ 6.5% APR) — tracked cost this book is judged against. Watching — No entry candidates evaluated today (daily session, no buys permitted). On watch for next review: GOOGL (recent "brain drain"/talent-retention headlines — monitor for any concrete guidance impact), PEP (soft relative performance vs KO, plus minor Ukraine plant incident — immaterial but tracking), NVDA (elevated volatility around AI capex headlines, screen still PASS on fundamentals). No exits triggered.

Session — Daily monitoring check (2026-08-31). Last screen 2026-08-25: 12/12 holdings PASS, breadth unchanged. Actions — No trades. News scan across all 12 holdings shows routine coverage (earnings recaps, analyst notes, competitive positioning, dividend commentary). No fraud, delisting risk, guidance collapse, or screen failures found. One item worth logging: a MarketBeat recap mentioned a "$18B settlement" tied to Meta — no primary-source detail or guidance impact found elsewhere; treating as noise pending review-day confirmation, not a thesis break. Macro backdrop: Iran/US strikes lifted oil, VIX ticked up to 15.2 (still calm, well below defensive threshold), indices modestly red. None of this touches individual holding fundamentals. Book — 12 positions, roughly equal-weighted 13.8%–14.9%. Gross exposure 1.71x vs 1.70x target (essentially at target, buy budget to target is -$581, i.e., no room — consistent with no-buy rule today anyway). Margin debit $70,400. Maintenance cushion: holdings can fall 41% before a margin call. Cumulative synthetic financing: $75.22 (today's accrual $75.22, first day tracked). Drawdown from HWM: 0.3% — well inside all risk-desk limits. Watching — Nothing near exit; all theses intact. For next review: (1) confirm nature/materiality of the Meta legal settlement headline before it's stale news; (2) monitor AMZN/GOOGL capex-funding divergence commentary for any margin-durability signal; (3) no new entry candidates evaluated today — universe re-screen happens at next deep review.

Session — Monthly deep review; 20/25 universe names PASS. Actions — Initiated full book from cash, 12 names at ~14.2% each (~$14,200 notional), targeting 1.70x gross: - MSFT (P/E21, ROE34%): cloud+enterprise software moat, network effects, fairly priced. - NVDA (P/E16, ROA-adj strong): AI GPU/CUDA ecosystem dominance, cheap for growth. - ADP (P/E21, ROE72%): payroll-processing switching costs, sticky enterprise relationships. - GOOGL (P/E24, ROE49%): search+YouTube+cloud moat, reasonable multiple. - META (P/E16, ROE30%): social network effects, scale advertising, cheapest mega-cap tech. - AMZN (P/E25, ROE31%): AWS+logistics scale moat. - MA (P/E26, ROA-adj strong): payment-network duopoly, high switching costs. - V (P/E25, ROE61%): payment-network duopoly, toll-road economics. - JNJ (P/E22, ROE26%): diversified pharma/med-device moat, defensive. - PEP (P/E16, ROE52%): brand/distribution scale, cheapest defensive. - KO (P/E26, ROE42%): global brand/distribution moat. - PG (P/E20, ROE30%): consumer-staples brand portfolio moat. Skipped EXPENSIVE-flagged AAPL, COST, WMT (P/E>30, no compelling edge over cheaper peers already held in-sector). Skipped NKE, CSCO, ACN, TXN, LLY to respect sector caps (Tech and Consumer Defensive both capped at 3) and prioritize best moat/valuation combination. Book — 12 positions, ~14.2% each, gross ≈170% (target 1.70x), sectors: Tech 3, Consumer Defensive 3, Communication Services 2, Financial Services 2, Consumer Cyclical 1, Healthcare 1 — all within 3-per-sector cap. Margin debit ≈$70,400. Maintenance cushion: fresh position, no prior debit history — monitor as fills settle. Cumulative synthetic financing: $0.00 (day one). Watching — LLY, TXN, CSCO, ACN, NKE (PASS, next in line if a slot opens); AAPL/COST/WMT for re-entry if valuations compress below 30x.